SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Litecoin is a peer-to-peer cryptocurrency created by Charlie Lee. It was created based on the Bitcoin protocol but differs in terms of the hashing algorithm used. Litecoin uses the memory intensive Scrypt proof of work mining algorithm. Scrypt allows consumer-grade hardware such as GPU to mine those coins.  Why Litecoin? Litecoin is a cryptocurrency that has evolved from Bitcoin after its own popularity in the industry, this alternative, or ‘altcoin’ has emerged to allow investors to diversify their digital currency package, according to Investopedia. Litecoin is one of the most prominent altcoins and was created by former Google employee and Director of Engineering at Coinbase, Charlie Lee. Litecoin was the first to alter Bitcoin and the most significant difference is that it takes 2.5 minutes for Litecoin to generate a block, or transaction, in comparison to Bitcoin's 10 minutes.  ‘While this matters little to traders, miners who use hardware to run Bitcoin's network cannot switch over to Litecoin. This keeps bigger mining conglomerates away from Litecoin because they cannot easily optimize their profits by swapping to another coin, contributing to a more decentralized experience. Litecoin also has bigger blocks, and more coins in circulation, making it more affordable and swift when transacting,’ Investopedia explained.  As explained above, Litecoin can transact a lot faster than Bitcoin, but there are also a number of other characteristics that investors need to know before trading. Litecoin can handle higher volumes of transactions because of the capability of transacting faster and if Bitcoin attempted to transact on the scale of its altcoin, a code update would be needed. However, Litecoin’s blocks would be larger, but with more ‘orphaned blocks'. The faster block time of litecoin reduces the risk of double spending attacks - this is theoretical in the case of both networks having the same hashing power.  Litecoin Technical Details: The transaction confirmation time taken for Litecoin is about 2.5 minutes on average (as compared to Bitcoin's 10 minutes). The Litecoin network is scheduled to cap at 84 million currency units.   Litecoin has inspired many other popular alternative currencies (eg. Dogecoin) because of its Scrypt hashing algorithm in order to prevent ASIC miners from mining those coins. However it is said that by the end of this year, Scrypt ASIC will enter the mass market.

Litecoin

Litecoin is trending as community members discuss recent price movements and potential future rallies, with some eyeing the $130 and $200 price range. Bullish sentiment is fueled by discussions of short squeezes and historical patterns, while others remain skeptical, pointing to LTC's past underperformance relative to other cryptocurrencies. Overall, the conversation revolves around whether Litecoin can sustain its current momentum amid broader market trends.

UnitedHealth Group, Inc. engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum's capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience. The OptumHealth segment provides health and wellness care, serving the broad health care marketplace including payers, care providers, employers, government, life sciences companies, and consumers. The OptumInsight segment focuses on data and analytics, technology, and information to help major participants in the healthcare industry. The OptumRx segment offers pharmacy care services. The company was founded by Richard T. Burke in January 1977 and is headquartered in Eden Prairie, MN.

Unitedhealth Group Inc

UnitedHealth Group ($UNH) is trending amidst concerns about potential impacts from government actions related to healthcare subsidies and the ACA. Community discussions revolve around whether Trump's proposals to redirect funds will hurt or help the company, with some arguing it could devastate smaller insurers and leave UNH as the only one standing. Investors are also closely watching for news on government shutdowns, potential impacts on earnings, and upcoming disclosures from major holders like Warren Buffett.

Uniting the six native Japanese dog breeds. Kendu is the keeper of peace, the preserver of life, and the protector of unity. Join the pack!!

Kendu

KENDU is trending as the community rallies around its real-world applications, from KENDU Energy to KENDU Unleashed skateboards, and the upcoming KENDU Games release on Steam. The community is actively discussing the best ways to "KENDU" everything, from real-life products to in-game integrations, reinforcing their belief in the long-term vision of the project. Holders are sharing bullish sentiments and celebrating the consistent building and marketing efforts of the project.

Internet Computer (IC) is the world’s first blockchain that is capable of running at web speed at unrestrictive capacities. Built by the DFINITY Foundation, IC aims to recreate the web by supporting smart contract development at scale and changing the way people can interact using web services. Internet Computer aims to extend the public internet, so that it can be the world’s computing platform, in a decentralized manner. Internet Computer sets to revolutionalize the design of the crypto economy, with an aim to overhaul traditional software services.   The project was founded in October 2016 by Dominic WIllams and have raised a total of $121 million from investors such as Adreessen Horowitz, Polychain Capital, Multicoin Capital and such. On May 10, 2021, DFINITY launched the Internet Computer into the public domain, marking it a major milestone for ICP as it means the internet now functions as a decentralised global computer. This is marked by the release of all of the Internet Computer’s source code into the public domain, as well as ICP utility token that allows tens of thousands of community members to govern the Internet Computer network.  ICP is Internet Computer's native token. It plays three prominent roles:  1. Network Governance: Users that participate in the governance will be rewarded with ICPI 2. Production of Cycles for Compute: ICP can be converted into cycles where it is used as the transaction fee to access the network. Cycles are burned after used. 3. Rewarding Users: ICP is used as the rewards to incentivize users to participate in the network such as securing the network.

Internet Computer

Internet Computer (ICP) is trending as the community discusses its potential and recent price action, with some speculating about a run to new highs. The focus is on ICP's technology and real-world utility, particularly with its integration of AI through Caffeine AI. Discussions also highlight the possibility of increased adoption and potential listings on major exchanges.

Oscar Health, Inc. is a health insurance company, which serves its customers through a technology platform. It offers individual and family, small group and medicare advantage plans, and technology platform to others within the provider and payor space. The company was founded by Mario Tobias Schlosser, Kevin Nazemi, and Joshua Kushner on October 25, 2012 and is headquartered in New York, NY.

Oscar Health Inc - Ordinary Shares - Class A

Oscar Health is trending amidst ongoing discussions around the Affordable Care Act (ACA) and its potential impact on the company's revenue, with some community members concerned about the consequences of its removal while others believe Oscar can thrive even without ACA subsidies. The stock's price volatility and upcoming earnings are also sparking active debate among investors regarding its future performance and long-term prospects, with some anticipating a significant rise while others remain bearish.

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Novo Nordisk - ADR

Novo Nordisk A/S

Novo Nordisk ($NVO) is trending due to market speculation surrounding its bidding war with Pfizer for Metsera, with community chatter focusing on the potential impact of winning or losing the deal and what it signals for NVO's pipeline and strategic direction; some traders believe NVO may be overpaying for the asset. Investors are also closely watching upcoming FDA decisions on oral treatments and potential price adjustments amid broader discussions on access to weight-loss drugs.

USDX (Website: usdx.money | Twitter: @StablesLabs) is a synthetic USD stablecoin designed to provide stability without relying on traditional banking infrastructure. Backed by delta-neutral positions across multiple exchanges, USDX seamlessly bridges the gap between DeFi, CeFi, and TradFi. It enables DeFi users to access traditional delta-neutral strategies executed in CeFi platforms. As a crypto-native stablecoin, USDX offers a scalable, censorship-resistant, and highly stable solution for users looking to navigate the world of decentralized finance with confidence.

USDX Stablecoin

USDX is trending as traders analyze its sideways movement, with focus on potential breakout scenarios and key resistance levels. Community discussions revolve around Elliott Wave patterns, high-frequency trading areas, and correlations with other Forex pairs like EURUSD and GBPUSD. Some traders are noting overbought conditions and potential reactions at extreme areas.

Fresenius Medical Care AG engages in the provision of products and services for individuals with renal diseases. It operates through the Care Enablement and Care Delivery segments. The Care Enablement segment is involved in the healthcare products business including research and development, manufacturing, supply chain, and commercial operations as well as supporting functions, such as regulatory and quality management. The Care Delivery segment focuses on the health care services for the treatment of CKD, ESRD, and other extracorporeal therapies, including value and risk-based care programs. The company was founded on August 5, 1996 and is headquartered in Bad Homburg, Germany.

Fresenius Medical Care AG - ADR

Fresenius Medical Care AG & Co. KGAA

Fresenius Medical Care is trending as investors discuss its recent Q3 earnings beat, which exceeded expectations due to organic growth and pricing momentum. Community members are also focused on the potential impact of DefenCath, with some suggesting its broader adoption could significantly improve patient outcomes and profitability for Fresenius. Discussions also involve the possible extension of the TDAPA policy and its effect on companies in the kidney care sector.

Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of medicines that treat intractable diseases by silencing the genes that cause them. The firms preclinical stage drug candidates include ARO-ANG3, ARO-AAT, ARO-APOC3, ARO-HIF2, ARO-HSD, ARO-Lung2, ARO-COV, and ARO-ENaC. The company was founded by Robert Bruce Stewart in 1989 and is headquartered in Pasadena, CA.

Arrowhead Pharmaceuticals Inc.

ARWR is trending amid discussions around its pipeline, recent presentations, and upcoming catalysts like the PDUFA date for Plozasiran. The community is focused on GSK presentations, potential FDA approval, and the obesity space, with some speculating about buyout possibilities. Community members are actively trading ARWR calls and analyzing potential market impacts.

Almonty Industries, Inc. engages in mining, processing and shipment of tungsten concentrates. Its projects include Los Santos, Valtreixal, Almonty Korea Tungsten, Almonty Korea Moly, and Panasquiera. The company was founded on September 28, 2009 and is headquartered in Toronto, Canada.

Almonty Industries Inc

Almonty Industries ($ALM) is trending as investors discuss the potential impact of rising tungsten prices and China's control of the tungsten market. The community is also closely watching for updates on the operational status of Almonty's plant, anticipating it will be a catalyst for growth. Recent news about Almonty acquiring a U.S. tungsten project has further fueled interest in the stock.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Bank of New York Mellon Corp Has $120.51 Million Stock Position in Insmed, Inc. $INSM

Bank of New York Mellon Corp lowered its holdings in shares of Insmed, Inc. (NASDAQ:INSM - Free Report) by 4.7% in the 2nd quarter, according to its most recent disclosure with the SEC. The fund...

C WorldWide Group Holding A S Cuts Stock Position in Insmed, Inc. $INSM

C WorldWide Group Holding A S lessened its position in Insmed, Inc. (NASDAQ:INSM - Free Report) by 15.6% during the 2nd quarter, according to its most recent filing with the Securities and Exchange...

Insider Selling: Insmed (NASDAQ:INSM) Insider Sells 27,130 Shares of Stock

Insmed, Inc. (NASDAQ:INSM - Get Free Report) insider Michael Alexander Smith sold 27,130 shares of the firm's stock in a transaction that occurred on Monday, November 3rd. The stock was sold at an...

Guru Fundamental Report for INSM

Below is Validea's guru fundamental report for INSMED INC (INSM). Of the 22 guru strategies we follow, INSM rates highest using our Quantitative Momentum Investor model based on the published...

Insmed To Present at November and December 2025 Investor Conferences

Insmed To Present at November and December 2025 Investor Conferences Insmed To Present at November and December 2025 Investor Conferences PR Newswire BRIDGEWATER, N.J., Nov. 5, 2025 BRIDGEWATER...

Latest read on rare disease gene therapy from Insmed CEO Will Lewis

Will Lewis, Insmed CEO, joins 'Fast Money' to talk Insmed's rare gene therapy development, demand, and quarterly results...

Insmed Misses on Q3 Earnings, Stock Rises on Strong Brinsupri Uptake

INSM shares jump 16% as Brinsupri's strong debut offset wider Q3 losses, lifting revenue 52% year over year.

Insmed (INSM) Reports Q3 Loss, Beats Revenue Estimates

Insmed (INSM) delivered earnings and revenue surprises of -32.58% and +24.16%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Insmed Reports Third-Quarter 2025 Financial Results and Provides Business Update

Insmed Reports Third-Quarter 2025 Financial Results and Provides Business Update Insmed Reports Third-Quarter 2025 Financial Results and Provides Business Update PR Newswire BRIDGEWATER, N.J., Oct...

Gear Up for Insmed (INSM) Q3 Earnings: Wall Street Estimates for Key Metrics

Beyond analysts' top-and-bottom-line estimates for Insmed (INSM), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended September 2025.

Insmed, Inc. is a global biopharmaceutical company, which engages in the development and commercialization of therapies for patients with rare diseases. Its focuses on Brensocatib, and Treprostinil Palmitil Inhalation Powder (TPIP) pipeline. The company was founded in 1988 and is headquartered in Bridgewater, NJ.

Insmed Inc

$ASTS

$RKLB

$BBAI

$NBIS

Which earnings release are you most excited for the week of Nov. 10? 
 
Drop a comment for others.

Current Price	$189.50
Prev Close	$185.68
Open	$184.10
Dividend Yield	0.00%
50-Day Moving Average	$157.32
Beta	0.82
Avg. Volume	2.13M
PE Ratio	-30.69

52-Week High	$197.08
52-Week Low	$60.40
Market Capitalization	$40.46B
EPS (Annual)	-$5.57
Price to Book	42.65
Revenue Per Employee	$286,158.14
Enterprise Value/EBITDA	N/A

INSM
Insmed Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest INSM News

INSMInsmed Inc